VistaGen Therapeutics Current Ratio 2008-2018 | VTGN

Current and historical current ratio for VistaGen Therapeutics (VTGN) from 2008 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. VistaGen Therapeutics current ratio for the three months ending June 30, 2018 was 4.19.
VistaGen Therapeutics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-06-30 $0.01B $0.00B 4.19
2018-03-31 $0.01B $0.00B 7.56
2017-12-31 $0.01B $0.00B 10.53
2017-09-30 $0.00B $0.00B 1.24
2017-06-30 $0.00B $0.00B 2.12
2017-03-31 $0.00B $0.00B 2.47
2016-12-31 $0.01B $0.00B 3.08
2016-09-30 $0.01B $0.00B 3.84
2016-06-30 $0.01B $0.00B 5.39
2016-03-31 $0.00B $0.00B 0.48
2015-12-31 $0.00B $0.00B 0.90
2015-09-30 $0.00B $0.00B 0.77
2015-06-30 $0.00B $0.00B 0.49
2015-03-31 $0.00B $0.02B 0.01
2014-12-31 $0.00B $0.01B 0.01
2014-09-30 $0.00B $0.01B 0.03
2014-06-30 $0.00B $0.01B 0.09
2014-03-31 $0.00B $0.01B 0.01
2013-12-31 $0.00B $0.01B 0.01
2013-09-30 $0.00B $0.00B 0.05
2013-06-30 $0.00B $0.00B 0.08
2013-03-31 $0.00B $0.00B 0.28
2012-12-31 $0.00B $0.00B 0.04
2012-09-30 $0.00B $0.00B 0.11
2012-06-30 $0.00B $0.00B 0.12
2012-03-31 $0.00B $0.00B 0.08
2011-12-31 $0.00B $0.00B 0.13
2011-09-30 $0.00B $0.01B 0.07
2011-06-30 $0.00B $0.01B 0.28
2011-03-31 $0.00B $0.01B 0.02
2010-12-31 $0.00B $0.00B 0.00
2010-09-30 $0.00B $0.00B 0.68
2010-06-30 $0.00B $0.00B 1.27
2010-03-31 $0.00B $0.00B 0.83
2009-12-31 $0.00B $0.00B 0.00
2009-09-30 $0.00B $0.00B 1.11
2009-06-30 $0.00B $0.00B 1.00
2009-03-31 $0.00B $0.00B 2.17
2008-12-31 $0.00B $0.00B 8.07
2008-09-30 $0.00B $0.00B 0.05
2008-06-30 $0.00B $0.00B 0.05
2008-03-31 $0.00B $0.00B 0.00
2007-12-31 $0.00B $0.00B 0.50
2007-09-30 $0.00B $0.00B 0.00
2007-06-30 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.053B $0.001B
VistaGen Therapeutics, Inc. is a biotechnology company. It is engaged in developing and commercializing product candidates for diseases and disorders involving the central nervous system. The company's lead product candidate consists of AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of major depressive disorder. VistaGen Therapeutics, Inc. is headquartered in South San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $126.600B 14.53
Gilead Sciences (GILD) United States $94.348B 10.47
Biogen (BIIB) United States $66.156B 14.02
Celgene (CELG) United States $57.556B 11.49
Illumina (ILMN) United States $46.071B 57.72
Vertex Pharmaceuticals (VRTX) United States $45.400B 103.29
Regeneron Pharmaceuticals (REGN) United States $40.796B 22.94
Alexion Pharmaceuticals (ALXN) United States $27.075B 20.35
BioMarin Pharmaceutical (BMRN) United States $17.661B 0.00
Incyte (INCY) United States $13.186B 443.07
Seattle Genetics (SGEN) United States $11.603B 0.00
Sarepta Therapeutics (SRPT) United States $8.727B 0.00
Exact Sciences (EXAS) United States $8.074B 0.00
Alnylam Pharmaceuticals (ALNY) United States $8.054B 0.00
QIAGEN (QGEN) Netherlands $7.826B 25.59
Bio-Techne Corp (TECH) United States $6.879B 46.01
BeiGene (BGNE) Cayman Islands $6.789B 0.00
Bluebird Bio (BLUE) United States $6.758B 0.00
Alkermes (ALKS) Ireland $6.449B 0.00
Amarin (AMRN) Ireland $5.639B 0.00
Galapagos (GLPG) Belgium $4.974B 0.00
Exelixis (EXEL) United States $4.739B 15.44
Ligand Pharmaceuticals (LGND) United States $4.222B 37.40
Immunomedics (IMMU) United States $3.776B 0.00
Myriad Genetics (MYGN) United States $3.261B 34.63
Ultragenyx Pharmaceutical (RARE) United States $3.101B 0.00
Horizon Pharma Public (HZNP) Ireland $3.069B 17.38
Emergent Biosolutions (EBS) United States $3.023B 24.08
Intercept Pharmaceuticals (ICPT) United States $3.002B 0.00
Blueprint Medicines (BPMC) United States $2.981B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $2.950B 0.00
Array BioPharma (ARRY) United States $2.930B 0.00
GUARDANT HEALTH (GH) United States $2.788B 0.00
ACADIA Pharmaceuticals (ACAD) United States $2.660B 0.00
Halozyme Therapeutics (HALO) United States $2.483B 33.10
Ascendis Pharma (ASND) Denmark $2.473B 0.00
China Biologic Products (CBPO) China $2.438B 16.76
ARGENX SE-ADR (ARGX) Netherlands $2.382B 0.00
Repligen (RGEN) United States $2.359B 79.18
Genomic Health (GHDX) United States $2.295B 128.00
Amicus Therapeutics (FOLD) United States $2.294B 0.00
Acceleron Pharma (XLRN) United States $2.238B 0.00
MyoKardia (MYOK) United States $2.143B 0.00
Medicines (MDCO) United States $1.987B 0.00
Akcea Therapeutics (AKCA) United States $1.959B 0.00
Cambrex (CBM) United States $1.943B 15.58
Arena Pharmaceuticals (ARNA) United States $1.940B 0.00
REGENXBIO (RGNX) United States $1.912B 30.04
AnaptysBio (ANAB) United States $1.826B 0.00
Spark Therapeutics (ONCE) United States $1.818B 0.00
Reata Pharmaceuticals (RETA) United States $1.818B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.775B 0.00
Global Blood Therapeutics (GBT) United States $1.695B 0.00
CRISPR THERAPTC (CRSP) Switzerland $1.694B 0.00
Atara Biotherapeutics (ATRA) United States $1.613B 0.00
Denali Therapeutics (DNLI) United States $1.612B 0.00
Puma Biotechnology (PBYI) United States $1.560B 0.00
Aimmune Therapeutics (AIMT) United States $1.557B 0.00
Innoviva (INVA) United States $1.523B 9.78
Myovant Sciences (MYOV) United Kingdom $1.468B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.467B 0.00
Clovis Oncology (CLVS) United States $1.466B 0.00
Allakos (ALLK) United States $1.426B 0.00
Sangamo Therapeutics (SGMO) United States $1.411B 0.00
G1 THERAPEUTICS (GTHX) United States $1.378B 0.00
WAVE Life Sciences (WVE) Singapore $1.372B 0.00
Rubius Therapeutics (RUBY) United States $1.365B 0.00
Mirati Therapeutics (MRTX) United States $1.331B 0.00
Editas Medicine (EDIT) United States $1.292B 0.00
Insmed (INSM) United States $1.265B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.202B 0.00
Solid Biosciences (SLDB) United States $1.149B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.146B 0.00
IMMURON LTD (IMRN) Australia $1.142B 0.00
Cellectis (CLLS) France $1.123B 0.00
Vanda Pharmaceuticals (VNDA) United States $1.118B 2134.00
NeoGenomics (NEO) United States $1.101B 192.71
Deciphera Pharmaceuticals (DCPH) United States $1.054B 0.00
DBV Technologies (DBVT) France $1.051B 0.00
UniQure (QURE) Netherlands $1.027B 0.00
Lion Biotechnologies (IOVA) United States $1.022B 0.00
Intra-Cellular Therapies (ITCI) United States $1.017B 0.00
Retrophin (RTRX) United States $1.006B 0.00
Audentes Therapeutics (BOLD) United States $1.006B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.978B 0.00
Intellia Therapeutics (NTLA) United States $0.969B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.965B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $0.927B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.918B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.907B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.903B 0.00
Coherus BioSciences (CHRS) United States $0.885B 0.00
Revance Therapeutics (RVNC) United States $0.884B 0.00
Athenex (ATNX) United States $0.883B 0.00
Apellis Pharmaceuticals (APLS) United States $0.875B 0.00
Acorda Therapeutics (ACOR) United States $0.866B 18.05
Aptinyx (APTX) United States $0.863B 0.00
Viking Therapeutics (VKTX) United States $0.861B 0.00
Dicerna Pharmaceuticals (DRNA) United States $0.814B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.784B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.783B 0.00
Cara Therapeutics (CARA) United States $0.762B 0.00
InflaRx (IFRX) Germany $0.761B 0.00
Novavax (NVAX) United States $0.746B 0.00
Epizyme (EPZM) United States $0.732B 0.00
Fate Therapeutics (FATE) United States $0.721B 0.00
CytomX Therapeutics (CTMX) United States $0.716B 0.00
Heska (HSKA) United States $0.708B 60.92
Dynavax Technologies (DVAX) United States $0.682B 0.00
Mesoblast (MESO) Australia $0.678B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.673B 0.00
ANI Pharmaceuticals (ANIP) United States $0.645B 12.78
AVROBIO (AVRO) United States $0.632B 0.00
ObsEva SA (OBSV) Switzerland $0.621B 0.00
UROGEN PHARMA (URGN) Israel $0.599B 0.00
Anika Therapeutics (ANIK) United States $0.599B 25.22
MiMedx (MDXG) United States $0.586B 25.14
AC Immune SA (ACIU) Switzerland $0.584B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.584B 0.00
Kura Oncology (KURA) United States $0.570B 0.00
Principia Biopharma (PRNB) United States $0.564B 0.00
Arcus Biosciences (RCUS) United States $0.547B 0.00
Vericel (VCEL) United States $0.522B 0.00
UNITY Biotechnology (UBX) $0.515B 0.00
Aduro Biotech (ADRO) United States $0.505B 0.00
Prothena (PRTA) Ireland $0.497B 0.00
RA PHARMCTL INC (RARX) United States $0.496B 0.00
Abeona Therapeutics (ABEO) United States $0.490B 0.00
Inovio Pharmaceuticals (INO) United States $0.489B 0.00
ARVINAS INC (ARVN) United States $0.482B 0.00
MediciNova (MNOV) United States $0.469B 0.00
Senesco Technologies (ELOX) United States $0.469B 0.00
Five Prime Therapeutics (FPRX) United States $0.466B 0.00
Stemline Therapeutics (STML) United States $0.464B 0.00
BeyondSpring (BYSI) United States $0.460B 0.00
Scholar Rock Holding (SRRK) United States $0.456B 0.00
Kezar Life Sciences (KZR) United States $0.449B 0.00
Verastem (VSTM) United States $0.438B 0.00
Liquidia Technologies (LQDA) United States $0.437B 0.00
Zealand Pharma (ZEAL) Denmark $0.432B 0.00
Zymeworks (ZYME) Canada $0.429B 0.00
Cytokineticsorporated (CYTK) United States $0.416B 0.00
Kindred Biosciences (KIN) United States $0.413B 0.00
Sinovac Biotech (SVA) China $0.412B 0.00
UROVANT SCIENCS (UROV) United States $0.410B 0.00
Sorrento Therapeutics (SRNE) United States $0.406B 69.60
Achillion Pharmaceuticals (ACHN) United States $0.403B 0.00
Nightstar Therapeutics Sponsored ADR (NITE) United States $0.395B 0.00
Replimune (REPL) United States $0.395B 0.00
MeiraGTx Holdings (MGTX) United States $0.381B 0.00
Keryx Biopharmaceuticals (KERX) United States $0.379B 0.00
PDL BioPharma (PDLI) United States $0.371B 5.20
KODIAK SCIENCES (KOD) United States $0.365B 0.00
Merus (MRUS) Netherlands $0.358B 0.00
Osiris Therapeutics (OSIR) United States $0.356B 0.00
GRITSTONE ONCLG (GRTS) United States $0.352B 0.00
Eidos Therapeutics (EIDX) United States $0.343B 0.00
Albireo Pharma (ALBO) United States $0.337B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.336B 0.00
Selecta Biosciences (SELB) United States $0.331B 0.00
SUTRO BIOPHARMA (STRO) United States $0.329B 0.00
Adverum Biotechnologies (ADVM) United States $0.317B 0.00
ResTORbio (TORC) United States $0.316B 0.00
Magenta Therapeutics (MGTA) United States $0.315B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.308B 0.00
Evelo Biosciences (EVLO) United States $0.308B 0.00
Peregrine Pharmaceuticals (CDMO) United States $0.306B 0.00
Kadmon Holdings (KDMN) United States $0.305B 0.00
Geron (GERN) United States $0.305B 0.00
Cellular Biomedicine (CBMG) United States $0.299B 0.00
Kala Pharmaceuticals (KALA) United States $0.298B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.295B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.294B 0.00
Axovant Sciences (AXON) United Kingdom $0.289B 0.00
Athersys (ATHX) United States $0.288B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.286B 0.00
Unum Therapeutics (UMRX) United States $0.285B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.275B 0.00
NantKwest (NK) United States $0.272B 0.00
Celcuity (CELC) United States $0.272B 0.00
Celyad SA (CYAD) Belgium $0.258B 0.00
Synlogic (SYBX) United States $0.256B 0.00
Syros Pharmaceuticals (SYRS) United States $0.255B 0.00
TOCAGEN INC (TOCA) United States $0.255B 0.00
BioTime (BTX) United States $0.254B 0.00
MannKind (MNKD) United States $0.252B 0.00
Seres Therapeutics (MCRB) United States $0.251B 0.00
ADMA Biologics Inc (ADMA) United States $0.248B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.242B 0.00
Kamada (KMDA) Israel $0.240B 18.59
Strongbridge Biopharma (SBBP) United States $0.236B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.234B 0.00
Allena Pharmaceuticals (ALNA) United States $0.233B 0.00
Arbutus Biopharma (ABUS) Canada $0.229B 0.00
Agenus (AGEN) United States $0.224B 0.00
BioDelivery Sciences (BDSI) United States $0.222B 0.00
Protagonist Therapeutics (PTGX) United States $0.220B 0.00
Krystal Biotech (KRYS) United States $0.220B 0.00
Idera Pharmaceuticals (IDRA) United States $0.219B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.215B 0.00
CorMedix Inc (CRMD) United States $0.213B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.208B 0.00
ChromaDex (CDXC) United States $0.199B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.198B 0.00
Enzo Biochem (ENZ) United States $0.195B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.188B 0.00
Cerecor (CERC) United States $0.187B 19.13
PSivida (EYPT) United States $0.186B 0.00
Mersana Therapeutics (MRSN) United States $0.185B 0.00
Palatin Technologies (PTN) United States $0.183B 7.56
Compugen (CGEN) Israel $0.182B 0.00
Clearside Biomedical (CLSD) United States $0.181B 0.00
Spero Therapeutics (SPRO) United States $0.177B 0.00
Constellation Pharmaceuticals (CNST) United States $0.177B 0.00
Cohbar (CWBR) United States $0.166B 0.00
Intec Pharma (NTEC) Israel $0.163B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.160B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.154B 0.00
Menlo Therapeutics (MNLO) United States $0.147B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.147B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.145B 0.00
OVID THERAPEUTC (OVID) United States $0.143B 0.00
Signal Genetics (MGEN) United States $0.141B 0.00
Monster Digital (INNT) United States $0.139B 0.00
Pfenex (PFNX) United States $0.136B 0.00
Cue Biopharma (CUE) United States $0.136B 0.00
VBI Vaccines (VBIV) United States $0.135B 0.00
Eleven Biotherapeutics (SESN) United States $0.133B 0.00
Mustang Bio (MBIO) United States $0.132B 0.00
Pluristem Therapeutics (PSTI) Israel $0.132B 0.00
XOMA (XOMA) United States $0.127B 13.39
Organovo Holdings (ONVO) United States $0.125B 0.00
Catalyst Biosciences (CBIO) United States $0.122B 0.00
Provention Bio (PRVB) United States $0.122B 0.00
Applied Genetic Technologies (AGTC) United States $0.121B 0.00
Motif Bio Plc (MTFB) United States $0.120B 0.00
ITUS (ANIX) United States $0.118B 0.00
Anavex Life Sciences (AVXL) United States $0.117B 0.00
XBiotech (XBIT) United States $0.117B 0.00
Cidara Therapeutics (CDTX) United States $0.111B 0.00
Tapimmune (TPIV) United States $0.106B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.103B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.102B 0.00
Cel-Sci (CVM) United States $0.101B 0.00
VTv Therapeutics (VTVT) United States $0.101B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.101B 0.00
BioXcel Therapeutics (BTAI) United States $0.100B 0.00
VolitionRX (VNRX) Singapore $0.098B 0.00
Aptevo Therapeutics (APVO) United States $0.098B 0.00
ScPharmaceuticals (SCPH) United States $0.097B 0.00
Orgenesis (ORGS) United States $0.094B 0.00
Neothetics (EVFM) United States $0.092B 0.00
Leap Therapeutics (LPTX) United States $0.090B 0.00
Axsome Therapeutics (AXSM) United States $0.088B 0.00
Chiasma (CHMA) United States $0.087B 0.00
Checkpoint Therapeutics (CKPT) United States $0.087B 0.00
Ophthotech (OPHT) United States $0.083B 0.54
Aptose Biosciences (APTO) Canada $0.082B 0.00
Prima BioMed (IMMP) Australia $0.082B 0.00
Cocrystal Pharma (COCP) United States $0.081B 0.00
NewLink Genetics (NLNK) United States $0.081B 0.00
Protalix BioTherapeutics (PLX) Israel $0.080B 0.00
OncoSec Medical (ONCS) United States $0.079B 0.00
Evogene (EVGN) Israel $0.078B 0.00
Alcobra (ARCT) United States $0.075B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.074B 0.00
Sophiris Bio (SPHS) United States $0.074B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.074B 0.00
Vaccinex (VCNX) United States $0.072B 0.00
Fortress Biotech (FBIO) United States $0.070B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.069B 0.00
Alimera Sciences (ALIM) United States $0.068B 0.00
Curis (CRIS) United States $0.068B 0.00
Celldex Therapeutics (CLDX) United States $0.068B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.067B 0.00
Oncobiologics (ONS) United States $0.066B 0.00
BIONANO GENOMIC (BNGO) United States $0.066B 0.00
Proteostasis Therapeutics (PTI) United States $0.065B 0.00
Entera Bio (ENTX) Israel $0.065B 0.00
Trevena (TRVN) United States $0.065B 0.00
Asterias Biotherapeutics (AST) United States $0.062B 0.00
Bellerophon Therapeutics (BLPH) United States $0.061B 0.00
Oncolytics Biotech (ONCY) Canada $0.055B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.053B 0.00
TRACON Pharmaceuticals (TCON) United States $0.051B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.048B 0.00
Celsion (CLSN) United States $0.047B 0.00
Zosano Pharma (ZSAN) United States $0.047B 0.00
Caladrius Biosciences (CLBS) United States $0.045B 0.00
AZURRX BIOPHARM (AZRX) United States $0.042B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
Advaxis (ADXS) United States $0.040B 0.00
GTx (GTXI) United States $0.039B 0.00
AquaBounty Technologies (AQB) United States $0.038B 0.00
Eyenovia (EYEN) United States $0.038B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.037B 0.00
Moleculin Biotech (MBRX) United States $0.037B 0.00
BioPharmX (BPMX) United States $0.036B 0.00
Aileron Therapeutics (ALRN) United States $0.035B 0.00
CytRx (CYTR) United States $0.031B 0.00
Proteon Therapeutics (PRTO) United States $0.029B 0.00
Cellect Biotechnology (APOP) Israel $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Galena Biopharma (SLS) United States $0.027B 0.00
Vical (VICL) United States $0.027B 0.00
Benitec Biopharma (BNTC) Australia $0.027B 0.00
OvaScience (OVAS) United States $0.027B 0.00
Edge Therapeutics (EDGE) United States $0.027B 0.00
AEterna Zentaris (AEZS) United States $0.025B 50.67
Gemphire Therapeutics (GEMP) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.022B 0.00
Arsanis (ASNS) United States $0.022B 0.00
ATyr Pharma (LIFE) United States $0.021B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.021B 0.00
Cleveland BioLabs (CBLI) United States $0.020B 0.00
RestorGenex (DFFN) United States $0.019B 0.00
Therapix Biosciences (TRPX) Israel $0.019B 6.88
Genetic Technologies (GENE) Australia $0.019B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Fibrocell Science Inc (FCSC) United States $0.018B 0.00
Soligenix (SNGX) United States $0.018B 0.00
Flex Pharma (FLKS) United States $0.017B 0.00
Prana Biotechnology (PRAN) Australia $0.017B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
TrovaGene (TROV) United States $0.017B 0.00
Adial Pharmaceuticals (ADIL) United States $0.017B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.017B 0.00
IBio (IBIO) United States $0.016B 0.00
Neuralstem (CUR) United States $0.016B 0.00
Novogen (KZIA) Australia $0.015B 0.00
Oragenics (OGEN) United States $0.013B 0.00
Cerulean Pharma (DARE) United States $0.013B 0.00
Vital Therapies (VTL) United States $0.013B 0.00
Alliqua BioMedical (ALQA) United States $0.012B 0.00
Hemispherx BioPharma (HEB) United States $0.010B 0.00
ImmunoCellular Therapeutics (IMUC) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.009B 0.00
MYOS RENS Technology (MYOS) United States $0.008B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.008B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.007B 0.00
Synthetic Biologics (SYN) United States $0.006B 0.00
AmpliPhi Biosciences (APHB) United States $0.005B 0.00
Titan Pharmaceuticals (TTNP) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.003B 0.00
Aytu Bioscience (AYTU) United States $0.002B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Y-MABS THERAPTC (YMAB) United States $0.000B 0.00